Haematology Guidelines
The Guidelines are organised by clinical area (haemato-oncology, general haematology, haemostasis and thrombosis and blood transfusion) and by status (whether they are current, archived or works in progress). They can be arranged either by date of publication OR alphabetically by 'topic' by clicking the arrows next to the column headings. The recommendations made by guidelines are reviewed regularly by the writing groups. They are updated as required and will be rewritten if changes are needed. Guidelines that are no longer valid will be archived.
Example: to view all current haemostasis and thrombosis guidelines press the 'haemostasis and thrombosis' tab and the 'current' tab. To view guidelines in production on blood transfusion, press the 'blood transfusion' and the 'works in progress' tab.
Search: The search function only works WITHIN THE PARAMETERS YOU HAVE SELECTED. Therefore to search all clinical areas please ensure you have selected 'All' in the clinical area tabs. Similarly if you want to search current, archived and works in progress, you must select 'ALL' from those options.
Review : Guidelines are reviewed every six months and are all current.
Date : This is the year the guidelines were last updated.
To view Archived Guidelines, please click here
You can also view Non-BCSH Guidelines by clicking here
Become Involved
There are many ways for members of the British Society for Haematology to become involved in BCSH from joining the sounding board that reviews and comments on the guidelines prior to publication to becoming part of the guideline Writing Groups or Task Forces.
Suggest a Guideline
BCSH welcomes suggested topics for new guidelines, which will be considered by the relevant Task Force.
Haematology Guidelines
 TOPIC |
GUIDELINE TITLE | DATE |
FULL GUIDE | PUBLISHED VERSION | AUDIT TEMPLATE | ||||
Haemophilia, inhibitors |
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia | 2013 |  |
||||||
Antithrombotic agents |
Guideline on the management of bleeding in patients on antithrombotic agents | 2012 | |
||||||
HIT, Heparin induced thrombocytopenia |
Guidelines on the diagnosis and management of Heparin induced thrombocytopenia: second edition
The diagnosis and management of heparin induced thrombocytopenia |
2012 | |
||||||
Assessment of anticoagulant intensity |
Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban | 2012 | |
||||||
Venous thrombosis, unusual sites |
Guidelines on the management of venous thrombosis at unusual sites | 2012 | |
||||||
Factor assays, coagulation |
Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis | 2012 | |
||||||
TTP |
Guidelines on the diagnosis and management of thrombocytopenic purpura and other thrombotic microangiopathies | 2012 | |
||||||
Antiphospholipid Syndrome |
Investigation and Management of Antiphospholipid Syndrome | 2012 | |
||||||
VTE, venous thrombosis |
The investigation, management and prevention of venous thrombosis in children | 2011 | |
||||||
Haemophilia |
The management of haemophilia in the fetus and neonate | 2011 | |
|
|||||
|
|||||||||
